AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 28/03/2011
PIL Losec I.V. Injection 40mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 15/03/2010 and displayed until 28/03/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/03/2009 and displayed until 15/03/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
Updated on 15/04/2008 and displayed until 13/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/02/2008 and displayed until 15/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 31/08/2006 and displayed until 25/02/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/08/2006 and displayed until 31/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/08/2006 and displayed until 29/08/2006
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change from BAN to rINN
Updated on 03/12/2004 and displayed until 04/08/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 04/09/2002 and displayed until 03/12/2004
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
   omeprazole sodium